1. PDS Biotechnology Appoints Renowned Oncologist Otis Brawley, MD to its Board of Directors

    PDS Biotechnology Appoints Renowned Oncologist Otis Brawley, MD to its Board of Directors

    ... Oncologic Drug Advisory Committee (ODAC). Dr. Brawley is a current member of the National Cancer Institute's (NCI) Board of Scientific Counselors ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. We are thrilled to welcome Dr. Brawley to the PDS Biotech Board of Directors. His board experience as well as his prodigious experience in oncology, from both a regulatory and a clinical perspective, will be invaluable for our team at this important point in our clinical progression.
  3. Topics Mentioned